PubRank

Michael T Lin

Author PubWeight™ 35.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 2005 2.70
2 Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004 2.64
3 Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004 1.92
4 Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. J Biol Chem 2007 1.52
5 Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One 2010 1.49
6 Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 2009 1.47
7 Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J 2010 1.44
8 Somatic mitochondrial DNA mutations in single neurons and glia. Neurobiol Aging 2004 1.37
9 Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 2009 1.37
10 Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol Aging 2004 1.36
11 Alzheimer's APP mangles mitochondria. Nat Med 2006 1.36
12 Heterologous mitochondrial DNA recombination in human cells. Hum Mol Genet 2004 1.23
13 Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease. J Neurochem 2009 1.17
14 MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 2010 1.15
15 Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses. Neurobiol Aging 2008 1.14
16 Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 2010 1.10
17 Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J Exp Med 2012 1.02
18 Impaired β-amyloid secretion in Alzheimer's disease pathogenesis. J Neurosci 2011 0.99
19 Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis 2010 0.95
20 Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem Biophys Res Commun 2002 0.91
21 Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2011 0.88
22 Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses. PLoS One 2013 0.87
23 Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Reson Imaging 2004 0.86
24 Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol 2012 0.86
25 High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils. Am J Pathol 2011 0.85
26 N-iminoethyl-L-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition. Neurochem Int 2009 0.84
27 The diagnostic utility of FLAIR imaging in clinically verified amyotrophic lateral sclerosis. J Magn Reson Imaging 2003 0.82
28 Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in rho(0) cells. Exp Neurol 2003 0.81
29 Hashimoto's encephalopathy mimicking spinocerebellar ataxia. J Neurol 2011 0.80
30 No evidence for heritability of Parkinson disease in Swedish twins. Neurology 2005 0.76